MedPath

Comparing the effectiveness of the drugs between Carbetocin and Oxytocin in the prevention of heavy blood loss during normal vaginal delivery

Phase 4
Conditions
Health Condition 1: O720- Third-stage hemorrhage
Registration Number
CTRI/2024/02/062430
Lead Sponsor
Dr Monisha S
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

SINGLETON PREGNANCY

TERM(37 TO 40 WEEKS OF GESTATION)

VAGINAL DELIVERY

Exclusion Criteria

AGE ABOVE 35 YEARS

PREVIOUS LOWER SEGMENT CAESAREAN SECTION

INSTRUMENTAL VAGINAL DELIVERY INCLUDING FORCEPS OR VACUUM ASSISTED

COMPLETE PERINEAL TEAR DURING NORMAL VAGINAL DELIVERY

HIGH RISK PREGNANCIES INCLUDING

ANTEPARTUM HEMORRHAGE

PLACENTA PREVIA

ABRUPTIO PLACENTA

PIH

PRE ECAMPSIA

ECLAMPSIA

GDM

MULTIPLE PREGNANCIES

POLYHYDRAMNIOS

MACROSOMIA

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath